Breakthrough Cancer Vaccine Shows 90% Efficacy in Clinical Trials
A new mRNA-based cancer vaccine has shown remarkable 90% efficacy in clinical trials.
AAdmin User
4 views
Revolutionary Cancer Prevention
Moderna personalized mRNA cancer vaccine achieved 90% efficacy in preventing melanoma recurrence.
- 90% reduction in cancer recurrence
- 6,500 participants across 200 sites
- 3-year follow-up data
#Medical
A